References
Koulu M, Saavedra JM, Niwa M, Scheinin M, Linnoila M. Association between increased serotonin metabolism in rat brainstem nuclei and development of spontaneous hypertension. Brain Research 371: 177–181, 1986
Krstic MK, Djurkovic D. Hypertension mediated by the activation of the brain 5-hydroxytryptamine receptor sites. Experientia 32: 1187–1189, 1976
Kuhn DM, Wolf WA, Lovenberg W. Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension 2: 243–255, 1980
McCall RB, Harris LT. Sympathetic alterations after midline medullary raphe lesions. American Journal of Physiology 253: R91–100, 1987
McCall RB, Humphrey SJ. Involvement of serotonin in the central regulation of blood pressure: evidence for a facilitating effect on sympathetic nerve activity. Journal of Pharmacology and Experimental Therapeutics 222: 94–102, 1982
Persson B, Hedner T, Henning M. Cardiovascular effects in the rat of ketanserin, a novel 5-hydroxytryptamine receptor blocking agent. Journal of Pharmacy and Pharmacology 34: 442–445, 1982
Schröder G, Beckmann R, Gerbling KH, Loge ?, Maass ?, et al. Pharmacological profile of a potent new 5-hydroxytryptamine/α1-receptor antagonist. Arzneimittel-Forschung 38: 765–770, 1988
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schulz, B.G., Schröder, G. & Stock, G. Contribution of Serotonergic Systems to Maintenance of Blood Pressure in Anaesthetised Normotensive Wistar Kyoto and Conscious Spontaneously Hypertensive Rats. Drugs 36 (Suppl 1), 102–104 (1988). https://doi.org/10.2165/00003495-198800361-00018
Published:
Issue Date:
DOI: https://doi.org/10.2165/00003495-198800361-00018